Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Incannex Healthcare Inc. - Common Stock (NQ: IXHL ) 1.880 +0.100 (+5.62%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Incannex Healthcare Inc. - Common Stock < Previous 1 2 3 4 5 6 7 8 Next > Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers August 07, 2023 Via Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances... Via Benzinga Incannex Healthcare: Is Life Better On Nasdaq? July 24, 2023 Incannex Healthcare is planning to redomicile to the US in a move designed to access deeper pools of capital and increase the company’s long-term market valuation. We interview the CEO of the... Via Talk Markets Cannabis Stock Gainers And Losers From August 4, 2023 August 04, 2023 Via Benzinga July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%, On Average July 30, 2023 All but 1 of the 6 largest psychedelic compound-based research & development stocks advanced in July and are ranked below as to their performances so far in July: Via Talk Markets Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial July 28, 2023 UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023: Via Benzinga Cannabis Stock Movers For August 3, 2023 August 03, 2023 Via Benzinga Incannex thrilled with positive pre-IND meeting for arthritis treatment July 27, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief scientific officer Dr Mark Bleackley tells Proactive the company has completed a constructive pre-Investigational New Drug (IND) application meeting... Via TheNewswire.com Exposures Product Safety Incannex thrilled with positive pre-IND meeting for arthritis treatment July 27, 2023 --News Direct-- Via News Direct Exposures Product Safety Marijuana Stock Movers For August 2, 2023 August 02, 2023 Via Benzinga Incannex Completes Positive Pre-IND Meeting With FDA On CBD-Based Drug For Treatment Of Rheumatoid Arthritis July 26, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has completed a constructive pre-Investigational New Drug Application (‘pre-IND’) meeting with the U.S. Via Benzinga Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD July 23, 2023 The psychedelic compound-based drug research and development sector is UP 13.6% MTD and is now UP 26.6% YTD and this article analyzes the performance of the 6 largest stocks in the Psychedelic Drug... Via Talk Markets Marijuana Stock Movers For August 1, 2023 August 01, 2023 Via Benzinga Incannex Submits IND Application To The FDA For Dronabinol-Based Drug For Obstructive Sleep Apnea July 21, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has successfully submitted an Investigational New Drug (‘IND’) application to the US Food and Drug Administration for IHL-42X for treatment of... Via Benzinga Incannex appoints CRO ahead of Phase 2/3 sleep apnoea trial July 18, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has engaged Fortrea as the contract research organisation (CRO) to manage the IND opening Phase 2/3 clinical... Via TheNewswire.com Cannabis Stock Gainers And Losers From July 28, 2023 July 28, 2023 Via Benzinga Incannex appoints CRO ahead of Phase 2/3 sleep apnoea trial July 18, 2023 --News Direct-- Via News Direct Cannabis Stock Gainers And Losers From July 26, 2023 July 26, 2023 Via Benzinga Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea July 18, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) has engaged Fortrea (NASDAQ: FTRE) as the contract research organisation for management of the IND opening p Via Benzinga Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD July 14, 2023 Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD. Via Talk Markets Cannabis Stock Movers For July 19, 2023 July 19, 2023 Via Benzinga Incannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis July 13, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus Research, Camberwell, Victoria, for its... Via Benzinga Incannex CEO talks plans to redomicile to US July 11, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has begun the process of shifting all outstanding shares to the Nasdaq after making the decision to redomicile... Via TheNewswire.com Incannex CEO talks plans to redomicile to US July 11, 2023 Incannex CEO talks plans to redomicile to US Via News Direct Incannex To Redomicile To United States, List All Shares On Nasdaq July 10, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) intends to redomicile from Australia to the United States via proposed schemes of arrangement between Incannex and its shareholders (share scheme)... Via Benzinga Psychedelic Stocks Jumped 10% Last Week July 09, 2023 The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly Via Talk Markets 12 Health Care Stocks Moving In Friday's Intraday Session July 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session July 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 06, 2023 Via Benzinga Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea July 06, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from Bellberry Human Research Ethics Committee to commence a bioavailability/bioequivalence (‘BA/BE’) clinical trial on... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.